BrightInsight and bioMérieux have partnered to develop a clinical digital solution for diagnostics, enabling clinical decision support for disease areas across diagnostic tests. bioMérieux will launch a digital solution for diagnostics leveraging the compliant BrightInsight Platform and BrightInsight Disease Management Solution; technology that can be configured to meet the highest regulated digital health Software as a Medical Device (SaMD) classifications. This solution aims to improve clinical workflows, contextualize disease awareness, and enable a more holistic patient view to support clinicians in making actionable, informed decisions.

• bioMérieux
  For more information, visit medlabmag.com/info